Cell cycle regulation by the PRMT6 arginine methyltransferase through repression of cyclin-dependent kinase inhibitors

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Kleinschmidt, Markus A ^a   de Graaf, Petra ^a   van Teeffelen, Hetty A A M ^a   Timmers, H Th Marc ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CYCLIN DEPENDENT KINASE INHIBITOR; HISTONE H3; PRMT6 PROTEIN; PROTEIN ARGININE METHYLTRANSFERASE; PROTEIN P21; PROTEIN P27; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE REGULATION; CONTROLLED STUDY; ENZYME INHIBITION; G2 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; GENE SILENCING; HISTONE METHYLATION; HUMAN; HUMAN CELL; OSTEOSARCOMA CELL; PROMOTER REGION; UPREGULATION;

BIOCATALYSIS; CELL CYCLE; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASE INHIBITOR PROTEINS; GENE KNOCKDOWN TECHNIQUES; HUMANS; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; PROTEIN-ARGININE N-METHYLTRANSFERASES; TRANSCRIPTION, GENETIC;

EID: 84865176464     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041446     Document Type: Article

References (43)

1. Vidal A, Koff A, ((2000)) Cell-cycle inhibitors: three families united by a common cause. Gene 247:: 1--15.
2. Abbas T, Dutta A, ((2009)) p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 9:: 400--414.
3. Mainprize TG, Taylor MD, Rutka JT, Dirks PB, ((2001)) Cip/Kip cell-cycle inhibitors: a neuro-oncological perspective. J Neurooncol 51:: 205--218.
4. Coqueret O, ((2003)) New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? Trends in Cell Biol 13:: 65--70.
5. Guccione E, Bassi C, Casadio F, Martinato F, Cesaroni M, et al. ((2007)) Methylation of histone H3R2 by PRMT6 and H3K4 by an MLL complex are mutually exclusive. Nature 449:: 933--937.
6. Hyllus D, Stein C, Schnabel K, Schiltz E, Imhof A, et al. ((2007)) PRMT6-mediated methylation of R2 in histone H3 antagonizes H3 K4 trimethylation. Genes Dev 21:: 3369--3380.
7. Iberg AN, Espejo A, Cheng D, Kim D, Michaud-Levesque J, et al. ((2008)) Arginine methylation of the histone H3 tail impedes effector binding. J Biol Chem 283:: 3006--3010.
8. Guccione E, Martinato F, Finocchiaro G, Luzi L, Tizzoni L, et al. ((2006)) Myc-binding-site recognition in the human genome is determined by chromatin context. Nat Cell Biol 8:: 764--770.
9. Kirmizis A, Santos-Rosa H, Penkett CJ, Singer MA, Vermeulen M, et al. ((2007)) Arginine methylation at histone H3R2 controls deposition of H3K4 trimethylation. Nature 449:: 928--932.
10. Vermeulen M, Mulder KW, Denissov S, Pijnappel WW, van Schaik FM, et al. ((2007)) Selective anchoring of TFIID to nucleosomes by trimethylation of histone H3 lysine 4. Cell 131:: 58--69.
11. Michaud-Levesque J, Richard S, ((2009)) Thrombospondin-1 is a transcriptional repression target of PRMT6. J Biol Chem 284:: 21338--21346.
12. Lee YH, Ma H, Tan TZ, Ng SS, Soong R, et al. (2012) Protein arginine methyltransferase 6 regulates ES cell identity, E pub ahead of print, doi:10.1089/scd.2011.0330.
13. Waldman T, Izzo A, Kamieniarz K, Richter F, Vogler C, et al. ((2011)) Methylation of H2AR29 is a novel repressive PRMT6 target. Epigenetics Chromatin 4:: 11--20.
14. El-Andaloussi N, Valovka T, Toueille M, Steinacher R, Focke F, et al. ((2006)) Arginine methylation regulates DNA polymerase beta. Mol Cell 22:: 51--62.
15. Boulanger MC, Liang C, Russell RS, Lin R, Bedford MT, et al. ((2005)) Methylation of Tat by PRMT6 regulates human immunodeficiency virus type 1 gene expression. J Virol 79:: 124--131.
16. Invernizzi CF, Xie B, Frankel FA, Feldhammer M, Roy BB, et al. ((2007)) Arginine methylation of the HIV-1 nucleocapsid protein results in its diminished function. Aids 21:: 795--805.
17. Fujiwara T, Mori Y, Chu DL, Koyama Y, Miyata S, et al. ((2006)) CARM1 regulates proliferation of PC12 cells by methylating HuD. Mol Cell Biol 26:: 2273--2285.
18. Jansson M, Durant ST, Cho EC, Sheahan S, Edelmann M, et al. ((2008)) Arginine methylation regulates the p53 response. Nat Cell Biol 10:: 1431--1439.
19. Pal S, Vishwanath SN, Erdjument-Bromage H, Tempst P, Sif S, ((2004)) Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes. Mol Cell Biol 24:: 9630--9645.
20. Scoumanne A, Zhang J, Chen X, ((2009)) PRMT5 is required for cell-cycle progression and p53 tumor suppressor function. Nucleic Acids Res 37:: 4965--4976.
21. Yu Z, Chen T, Hebert J, Li E, Richard S, ((2009)) A mouse PRMT1 null allele defines an essential role for arginine methylation in genome maintenance and cell proliferation. Mol Cell Biol 29:: 2982--2996.
22. Torres-Padilla ME, Parfitt DE, Kouzarides T, Zernicka-Goetz M, ((2007)) Histone arginine methylation regulates pluripotency in the early mouse embryo. Nature 445:: 214--218.
23. Wu Q, Bruce AW, Jedrusik A, Ellis PD, Andrews RM, et al. ((2009)) CARM1 is required in ES Cells to maintain pluripotency and resist differentiation. Stem Cells 27:: 2637--2645.
24. Polotskaia A, Wang M, Patschan S, Addabbo F, Chen J, et al. ((2007)) Regulation of arginine methylation in endothelial cells: role in premature senescence and apoptosis. Cell Cycle 6:: 2524--2530.
25. Kim C, Lim Y, Yoo BC, Won NH, Kim S, et al. ((2010)) Regulation of post-translational protein arginine methylation during HeLa cell cycle. Biochem Biophys Acta 1800:: 977--985.
26. Lim Y, Lee E, Lee J, Oh S, Kim S, ((2008)) Down-regulation of asymmetric arginine methylation during replicative and H2O2-induced premature senescence in WI-38 human diploid fibroblasts. J Biochem 144:: 523--529.
27. Zhang X, Zhou L, Cheng X, ((2000)) Crystal structure of the conserved core of protein arginine methyltransferase PRMT3. Embo J 19:: 3509--3519.
28. Zhang X, Cheng X, ((2003)) Structure of the predominant protein arginine methyltransferase PRMT1 and analysis of its binding to substrate peptides. Structure 11:: 509--520.
29. Harrison MJ, Tang YH, Dowhan DH, ((2010)) Protein arginine methyltransferase 6 regulates multiple aspects of gene expression. Nucleic Acids Res 38:: 2201--2216.
30. Gillespie DA, Walker M, ((2006)) Mitotic index determination by flow cytometry. Subcell Biochem 40:: 355--358.
31. Smits VA, Klompmaker R, Vallenius T, Rijksen G, Makela TP, et al. ((2000)) p21 inhibits Thr161 phosphorylation of Cdc2 to enforce the G2 DNA damage checkpoint. J Biol Chem 275:: 30638--30643.
32. Xie B, Invernizzi CF, Richard S, Wainberg MA, ((2007)) Arginine methylation of the human immunodeficiency virus type 1 Tat protein by PRMT6 negatively affects Tat Interactions with both cyclin T1 and the Tat transactivation region. J Virol 81:: 4226--4234.
33. Herrmann F, Pably P, Eckerich C, Bedford MT, Fackelmayer FO, ((2009)) Human protein arginine methyltransferases in vivo-distinct properties of eight canonical members of the PRMT family. J Cell Sci 122:: 667--677.
34. Iberg AN, Espejo A, Cheng D, Kim D, Michaud-Levesque K, et al. ((2008)) Arginine methylation of the histone H3 tail impedes effector binding. J Biol Chem 283:: 3006--3010.
35. Kottemann MC, Bale AE, ((2009)) Characterization of DNA damage-dependent cell cycle checkpoints in a menin-deficient model. DNA Repair (Amst) 8:: 944--952.
36. Milne TA, Hughes CM, Lloyd R, Yang Z, Rozenblatt-Rosen O, et al. ((2005)) Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors. Proc Natl Acad Sci U S A 102:: 749--754.
37. Yoshimatsu M, Toyokawa G, Hayami S, Unoki M, Tsunoda T, et al. ((2011)) Dysregulation of PRMT1 and PRMT6, type I arginine methyltransferases, is involved in various type of human cancers. Int J Cancer 128:: 562--573.
38. Huang S, ((2002)) Histone methyltransferases, diet nutrients and tumour suppressors. Nat Rev Cancer 2:: 469--476.
39. Weiss RH, ((2003)) p21Waf1/Cip1 as a therapeutic target in breast and other cancers. Cancer Cell 4:: 425--429.
40. Wagner S, Weber S, Kleinschmidt MA, Nagata K, Bauer UM, ((2006)) SET-mediated promoter hypoacetylation is a prerequisite for coactivation of the estrogen-responsive pS2 gene by PRMT1. J Biol Chem 281:: 27242--27250.
41. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, et al. ((1993)) WAF1, a potential mediator of p53 tumor suppression. Cell 75:: 817--825.
42. Mannefeld M, Klassen E, Gaubatz S, ((2009)) B-MYB is required for recovery from the DNA damage-induced G2 checkpoint in p53 mutant cells. Cancer Res 69:: 4073--4080.
43. Kleinschmidt MA, Streubel G, Samans B, Krause M, Bauer UM, ((2008)) The protein arginine methyltransferases CARM1 and PRMT1 cooperate in gene regulation. Nucleic Acids Res 36:: 3202--3213.